Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 826-39-1, Inversine, Mevasin, Mecamylamine (hydrochloride), Mevasine, Mecamylamine hcl
Molecular Formula
C11H22ClN
Molecular Weight
203.75  g/mol
InChI Key
PKVZBNCYEICAQP-UHFFFAOYSA-N
FDA UNII
4956DJR58O

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N,2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine;hydrochloride
2.1.2 InChI
InChI=1S/C11H21N.ClH/c1-10(2)8-5-6-9(7-8)11(10,3)12-4;/h8-9,12H,5-7H2,1-4H3;1H
2.1.3 InChI Key
PKVZBNCYEICAQP-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1(C2CCC(C2)C1(C)NC)C.Cl
2.2 Other Identifiers
2.2.1 UNII
4956DJR58O
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 826-39-1

2. Inversine

3. Mevasin

4. Mecamylamine (hydrochloride)

5. Mevasine

6. Mecamylamine Hcl

7. N,2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine Hydrochloride

8. Mecamylamine, Hcl

9. N,2,3,3-tetramethyl-2-norbornanamine Hydrochloride

10. Nsc-757086

11. Mecamylamine Hydrochloride [usp]

12. 4956djr58o

13. Bicyclo(2.2.1)heptan-2-amine, N,2,3,3-tetramethyl-, Hydrochloride

14. Mekamin Hydrochloride

15. Mecamine Hydrochloride

16. Mecamylamine Hydrochloride (usp)

17. Vecamyl

18. Sr-01000075329

19. Einecs 212-555-8

20. 3-methylaminoisocamphane Hydrochloride

21. 3-methylaminoisokamfan Chlorid [czech]

22. Inversin

23. N-methyl-dl-isobornylamine Hydrochloride

24. Inversene

25. N,2,2,3-tetramethylbicyclo[2.2.1]heptan-3-amine;hydrochloride

26. 3-methylaminoisokamfan Chlorid

27. Unii-4956djr58o

28. Cpdb 0059

29. Inversine (tn)

30. Mecamylamine Chloride

31. 2-norbornanamine, N,2,3,3-tetramethyl-, Hydrochloride

32. N-methyl-n-2,5-endomethylene-1,6,6-trimethylcyclohexylamine Hydrochloride

33. Atg-3

34. Schembl123951

35. Chebi:6707

36. Chembl1237082

37. Niosh/rb7466510

38. Agi-004

39. Atg-003

40. Dtxsid70896795

41. Hms1571o04

42. Pharmakon1600-01500374

43. Hy-b1395

44. Tox21_500841

45. Ccg-39679

46. Mfcd00151462

47. Nsc757086

48. Akos015963326

49. Asa 185/13

50. Lp00841

51. Mecamylamine Hydrochloride [mi]

52. Nsc 757086

53. 2-(methylamino)isocamphane Hydrochloride

54. Ncgc00094171-01

55. Ncgc00094171-02

56. Ncgc00094171-03

57. Ncgc00261526-01

58. Ac-19862

59. Ls-14021

60. Mecamylamine Hydrochloride [mart.]

61. Mecamylamine Hydrochloride [vandf]

62. Mecamylamine Hydrochloride [usp-rs]

63. Mecamylamine Hydrochloride [who-dd]

64. 2-[1,2,4]triazol-1-ylmethyl-benzoicacid

65. Db-056643

66. Cs-0013122

67. Eu-0100841

68. Ft-0603516

69. Ft-0670962

70. Ft-0670963

71. Ft-0670964

72. Rb74665100

73. D00611

74. M 9020

75. Mecamylamine Hydrochloride [orange Book]

76. Mecamylamine Hydrochloride [usp Monograph]

77. N,2,3,3-tetramethyl-2-norcamphanamine Hydrochloride

78. Q-201341

79. Sr-01000075329-1

80. Sr-01000075329-6

81. Q27259230

82. 2-(methylamino)-2,3,3-trimethylnorbornane Hydrochloride

83. Mecamylamine Hydrochloride 100 Microg/ml In Acetonitrile

84. N,2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine;hydrochloride

85. Norbornane, 2-(methylamino)-2,3,3-trimethyl-, Hydrochloride

86. Bicyclo[2.2.1]heptan-2-amine, N,2,3,3-tetramethyl-, Hydrochloride (1:1)

2.4 Create Date
2005-03-27
3 Chemical and Physical Properties
Molecular Weight 203.75 g/mol
Molecular Formula C11H22ClN
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count1
Rotatable Bond Count1
Exact Mass203.1440774 g/mol
Monoisotopic Mass203.1440774 g/mol
Topological Polar Surface Area12 Ų
Heavy Atom Count13
Formal Charge0
Complexity197
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count3
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameMecamylamine hydrochloride
Active IngredientMecamylamine hydrochloride
Dosage FormTablet
RouteOral
Strength2.5mg
Market StatusPrescription
CompanyNexgen Pharma

2 of 2  
Drug NameMecamylamine hydrochloride
Active IngredientMecamylamine hydrochloride
Dosage FormTablet
RouteOral
Strength2.5mg
Market StatusPrescription
CompanyNexgen Pharma

5 Pharmacology and Biochemistry
5.1 FDA Pharmacological Classification
5.1.1 Pharmacological Classes
Decreased Autonomic Ganglionic Activity [PE]; Autonomic Ganglionic Blocker [EPC]